Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

AP Biosciences, Inc. (6945) Financial Statements

AP Biosciences, Inc. Financial Overview

AP Biosciences, Inc.'s market cap is currently NT$11.22B. The company's EPS TTM is NT$-5.40; its P/E ratio is -20.83; AP Biosciences, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 0.00NT$ 0.00NT$ 32.25MNT$ 0.00NT$ 6.99M
Gross ProfitNT$ -25.52MNT$ -17.48MNT$ 32.25MNT$ -8.68MNT$ 6.99M
Operating IncomeNT$ -456.38MNT$ -439.06MNT$ -347.48MNT$ -288.54MNT$ -186.72M
EBITDANT$ -430.86MNT$ -403.61MNT$ -325.51MNT$ -290.07MNT$ -177.86M
Net IncomeNT$ -444.77MNT$ -422.75MNT$ -339.30MNT$ -288.54MNT$ -187.61M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.17BNT$ 1.54BNT$ 740.02MNT$ 1.08BNT$ 557.12M
Total AssetsNT$ 1.37BNT$ 1.73BNT$ 890.76MNT$ 1.10BNT$ 579.35M
Total DebtNT$ 59.51MNT$ 70.91MNT$ 82.08MNT$ 0.00NT$ 0.00
Net DebtNT$ -911.38MNT$ -1.37BNT$ -196.53MNT$ -1.05BNT$ -527.12M
Total LiabilitiesNT$ 94.22MNT$ 104.38MNT$ 106.65MNT$ 4.52MNT$ 21.15M
Stockholders' EquityNT$ 1.27BNT$ 1.62BNT$ 784.11MNT$ 1.10BNT$ 558.20M
Cash Flow
Free Cash FlowNT$ -377.35MNT$ -363.40MNT$ -333.03MNT$ -278.41MNT$ -173.60M
Operating Cash FlowNT$ -352.09MNT$ -357.88MNT$ -297.62MNT$ -275.97MNT$ -168.68M
Investing Cash FlowNT$ -125.25MNT$ 326.37MNT$ -468.68MNT$ -3.15MNT$ -34.92M
Financing Cash FlowNT$ 4.51MNT$ 1.20BNT$ -3.10MNT$ 800.00MNT$ 100.00M

Currency in TWD

AP Biosciences, Inc. Earnings and Revenue History

-500M-250M0250M-3000 %-1500 %0 %1500 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

AP Biosciences, Inc. Liabilities to Assets

0800M1.6B2.4B0 %5 %10 %15 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

AP Biosciences, Inc. Cash Flow

-1B-500M0500M1B1.5B202020212022202320242025OperatingInvestingFinancing
Cash Flow >

AP Biosciences, Inc. Forecast EPS vs Actual EPS

-2.5-2.2-2-1.7-1.5-1.2-1-0.7Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >